Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10081944 | 0.89 | MAPT (0.52) | TP53MAPTMAPK1RAB9AALDH1A1 | |
| SCHEMBL91554 | 0.88 | PDE5A (0.53) | MAPTMAPK1RAB9AALDH1A1KMT2A | |
| SCHEMBL91572 | 0.88 | RAB9A (0.66) | TP53MAPTMAPK1RAB9AALDH1A1 | |
| SCHEMBL91611 | 0.79 | FPR2 (0.55) | MAPTMAPK1RAB9AKMT2ASMN1; SMN2 | |
| SCHEMBL77635 | 0.78 | KMT2A (0.70) | MAPTMAPK1RAB9AALDH1A1KMT2A | |
| SCHEMBL6376711 | 0.77 | MAPT (0.55) | TP53MAPTMAPK1RAB9ANPC1 | |
| SCHEMBL10081941 | 0.77 | MAPK1 (0.57) | TP53MAPTMAPK1RAB9AALDH1A1 | |
| SCHEMBL91587 | 0.76 | MAPK1 (0.63) | TP53MAPTMAPK1RAB9AALDH1A1 | |
| SCHEMBL2175797 | 0.76 | SMN1; SMN2 (0.50) | MAPK1RAB9AALDH1A1KMT2ANPC1 | |
| SCHEMBL2612387 | 0.75 | SMN1; SMN2 (0.73) | MAPTRAB9AALDH1A1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129415-B2 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | HAAO, HAO1, CYP51A1 | TP53 3299/4885MAPT 2769/4885MAPK1 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.